As of 2025-07-06, the Fair Value of Werewolf Therapeutics Inc (HOWL) is -8.07 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.07 USD, the upside of Werewolf Therapeutics Inc is -854.11%.
With the market price of 1.07 USD and our fair value calculation, Werewolf Therapeutics Inc (HOWL) is not a good investment. Investing in HOWL stocks now will result in a potential loss of 854.11%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -15.04 | -49.98 | -53.81 | -37.37 | -70.51 | -45.34 |
| YoY growth | -46.73% | -232.31% | -7.66% | 30.56% | -88.70% | -68.97% |
| Market Cap (mil) | 48.01 |
| P/E | |
| Forward P/E |
| EPS | -1.61 |
| Avg earnings growth rate | -68.97% |
| TTM earnings | -72.41 |